#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary arterial hypertension Neuroendocrine tumour Fragile X syndrome Peripheral primitive neuroectodermal tumour of soft tissue Angelman's syndrome Rectal cancer Follicular lymphoma stage II Phenylketonuria Progressive supranuclear palsy Pneumonia Usher's syndrome Neurodevelopmental disorder Erythema multiforme Small cell lung cancer recurrent Neoplasm malignant More trials…

    Learn about Rare Diseases

    Hypereosinophilic syndrome – Treatment Inclusion body myositis – Basic Information Mantle cell lymphoma stage II – Trials in Disease Ehlers-Danlos syndrome – Diagnostics Epidermolysis bullosa Krabbe’s disease – Basic Information Uterine leiomyosarcoma – Basic Information Leiomyosarcoma – Trials in Disease Lymphangiosarcoma – Life with Disease Undifferentiated sarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rosuvastatin Zinc ALPROSTADIL Spiramycin Maribavir Iberdomide Gallium (68Ga) Chloride Daratumumab Venlafaxine Hydrochloride Tertomotide Water For Injections Sulfonamides, Urea Derivatives Zongertinib Buloxibutid Lidocaine ABBV-8736 Botaretigene Sparoparvovec Desoximetasone Anitocabtagene Autoleucel Ucart20X22 Bi 1839100 More therapies…

    Learn about Your Condition

    Narcolepsy Bronchopulmonary aspergillosis Arrhythmia supraventricular Metastases to liver Juvenile absence epilepsy Hyperadrenocorticism Pseudoxanthoma elasticum Primary hypercholesterolaemia Thyroid cancer Skin bacterial infection Dementia Alzheimer's type Ocular melanoma Thrombosis prophylaxis Alexander disease Anaemia of pregnancy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pathological Conditions, Signs and Symptoms

  • Study on Iron Infusion with Ferric Carboxymaltose for Elderly Patients with Severe Aortic Stenosis and Iron Deficiency Undergoing TAVI

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Aortic stenosis
    • Iron deficiency
    Investigated Drugs:
    • Ferric Carboxymaltose
    The Netherlands

  • OM336 for Desensitization in Patients with End-Stage Renal Failure Awaiting Kidney Transplantation

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Valaciclovir
    • Buclizine Hydrochloride
    • Codeine Phosphate
    Austria

  • A study testing ALXN2030 for adults with antibody-mediated rejection after kidney transplantation

    Not recruiting

    2 1
    Investigated Drugs:
    • RNA, (AM-SP-UM-CM-AM-AM-CM-UM-(2′-DEOXY-2′-FLUORO)C-(2′-DEOXY-2′-FLUORO)A-(2′-DEOXY-2′-FLUORO)C-(2′-DEOXY-2′-FLUORO)C-UM-GM-UM-AM-AM-UM-AM-AM-AM-GM-CM-AM-GM-CM-CM-GM-[2′-O-[[2-[2-[[5-[[2-(ACETYLAMINO)-2-DEOXY-BETA-D-GALACTOPYRANOSYL]OXY]-1-OXOPENTYL]AMINO]ETHOXY]ETHOXY]METHYL]]A-[2′-O-[[2-[2-[[5-[[2-(ACETYLAMINO)-2-DEOXY-BETA-D-GALACTOPYRANOSYL]OXY]-1-OXOPENTYL]AMINO]ETHOXY]ETHOXY]METHYL]]A-[2′-O-[[2-[2-[[5-[[2-(ACETYLAMINO)-2-DEOXY-BETA-D-GALACTOPYRANOSYL]OXY]-1-OXOPENTYL]AMINO]ETHOXY]ETHOXY]METHYL]]A-GM-GM-CM-UM-GM-CM), COMPLEX WITH RNA ([4′-DE(HYDROXYMETHYL)-4′-[(HYDROXYMETHOXYPHOSPHINYL)METHOXY]]UM-SP-(2′-DEOXY-2′-FLUORO)U-SP-(2′-DEOXY-2′-FLUORO)U-(2′-DEOXY-2′-FLUORO)A-(2′-DEOXY-2′-FLUORO)U-UM-(2′-DEOXY-2′-FLUORO)A-CM-AM-(2′-DEOXY-2′-FLUORO)G-GM-UM-GM-(2′-DEOXY-2′-FLUORO)A-GM-UM-UM-GM-AM-UM-SP-GM-SP-GM)
    Spain

  • Study of Monthly Atacicept Injections in Patients with IgA Nephropathy (Berger Disease)

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Atacicept
    Poland Spain

  • Study on the Use of Indocyanine Green to Assess Lymphatic Vessel Porosity in Women with Lipedema

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Indocyanine Green
    Belgium

  • Study on Midazolam and Morphine for Symptom Relief in Elderly Patients at End of Life

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • MORPHINE
    Belgium
Previous Page
1 … 13 14 15 16 17 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!